PT Kalbe Farma Tbk. (IDX:KLBF)

Market Cap	55.14T
Revenue (ttm)	32.63T
Net Income (ttm)	3.24T
Shares Out	45.95B
EPS (ttm)	70.16
PE Ratio	17.10
Forward PE	16.03
Dividend	31.00 (2.58%)
Ex-Dividend Date	May 29, 2024

Volume	43,557,100
Average Volume	51,861,595
Open	1,255.00
Previous Close	1,255.00
Day's Range	1,185.00 - 1,260.00
52-Week Range	985.00 - 1,795.00
Beta	0.16
RSI	54.73
Earnings Date	Mar 27, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the comp...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,903
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KLBF

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.